upgrad outperform think current pullback present
attract entri point bast-in-class hcit name think could affect
n-t book revenue believ fundament posit l-t outlook
remain intact think could upsid strateg growth busi
especi w/ potenti acq target discount valuat
mgmt focu drive op effici target margin follow cooper
agreement starboard thought could materi advers impact l-t
top-lin growth howev cern l-t revenue growth target vs previou
indic l-t growth prospect remain larg intact reduct l-t
revenue growth target like reflect cern decis select certain lower
margin oppti also expect achiev adj op margin l-t adj
ep growth high-singl digit low-doubl digit although believ consist adj ep
low- mid-teen achiev
cern strateg growth busi compris target market health network
data-as-a-servic real-tim continuum workforc servic
consum believ market repres consider oppti growth given
tam surmount barrier entri particularli like oppti real-
world evid health network
think could advers impact cern book n-t
hospit focu pandem like deemphas new purchas would
unsurpris report book toward low end guid
softer book expect revenu impact well result
due delay go-liv lower book
l-t think could benefit increas demand
healtheint view like enhanc valu pop health addit
may inclin make strateg acquisit given significantli discount
valuat due
believ pullback present attract opportun construct
trade adj ep estimate believ share under-valued
current level l-t growth profil warrant price-to-earnings multipl rang
view
pleas see page report import disclosur
posit believ best-in-class hcit name compani
well posit growth feder dod va strateg growth busi
along stabl busi notabl believ management long-term target
revenu adj oper margin high-singl low-doubl digit growth
adj ep achiev share repurchas think adj ep growth low-
-mid-teen like believ growth profil warrant price-to-earnings ratio
progress achiev adj oper
progress strateg growth
updat dod va contract
top-lin growth
book growth y/i
oper margin almost
digit driven better expect
flat sale growth due slower
oper margin
lead provid inform technolog solut hospit healthcar
provid primarili solut implement stand-alon combin
enterprise-wid system design provid clinic financi inform
manag tool healthcar marketplac system design suppli
appropri health inform knowledg provid real-tim basi
compani also offer wide array servic includ implement train remot
host oper manag servic revenu cycl servic support mainten
health center employe well program third-parti administr servic
manag focu drive oper effici achiev target adj
oper margin follow cooper agreement starboard thought
could materi advers impact long-term top-lin growth howev cern
long-term revenu growth target compar previou rang
indic compani long-term growth prospect remain larg intact
percentag point reduct long-term revenu growth target like reflect
cern decis select certain lower margin opportun organ
growth target expect driven feder growth target
strateg growth growth target busi busi
expect declin due shift revenu servic resourc
feder va ramp figur inorgan growth expect contribut
long-term revenu growth note investor express level
disappoint inorgan growth compon cern long-term revenu
growth target previou long-term revenu growth assum inorgan
growth well
addit grow revenu expect achiev adj
oper margin averag annual margin expans bp
adj oper margin impli guidanc figur adj
oper margin target driven transform offic focus
growth strategi higher contribut margin sg leverag notabl
cern adj oper margin target came ahead expect
also target long-term adj ep growth high-singl digit low-doubl
digit although believ consist adj ep low- mid-teen achiev
share repurchas
compani report cowen compani
compani report cowen compani
cern strateg growth busi compris six target market
workforc health servic consum believ market repres
consider opportun growth given tam least
billion surmount barrier entri figur addit believ
reach market share least six growth market
combin billion market share repres billion
think cern long-term strateg growth revenu target achiev
fact strateg growth revenu grew y/i million million
figur
figur compound-annual-growth-rate strateg growth market
compani report cowen compani
million
compani report cowen compani
think daa busi repres consider opportun particularli real-
world evid rwe market estim billion
nascent stage develop rwe busi collabor duke clinic
research institut alreadi yield valu biopharma project line
nvo panel recent host confer
indic valu rwe provid biopharma particularli optim clinic trial
acceler approv expand indic panelist note
current licens data vendor think biopharma see
valu data healtheint platform given static
compris data variou ehr vendor biopharma current use smaller
vendor specif data set capabl trinetx think could
make logic acquisit target look bolster rwe
also think cern partnership lumeri play signific role drive
growth network busi within strateg growth combin
technolog servic lumeri enabl help health system
manag complex value-bas arrang includ medicar advantag
provider-sponsor health plan control cost improv outcom fact
invest commun meet note intend migrat eight legaci
client plu essenc health healtheint part lumeri partnership
recal juli announc relationship lumeri elimin
ineffici healthcar system launch maestro advantag value-bas
comfort high level visibl cern feder busi
give us greater confid achiev manag long-term growth
target nearli cern revenu recur highli visibl similar
revenu recur highli visibl given
depart defens dod depart veteran affair va contract run
respect visibl larg part cern
revenu throughout long-term target time-frame dod contract
deploy timelin consist wave earli va contract
deploy timelin consist wave earli figur importantli
convers manag indic deploy activ dod
va progress on-tim despit pandem
figur dod va program timelin
think current pandem could advers impact cern
contract book near-term hospit focu manag
pandem like deemphas new purchas cern contract book
guidanc stand billion would unsurpris compani
report contract book toward low end rang given typic
hcit book cadenc major contract book sign toward
end quarter lower contract book estim
billion previou estim billion addit pandem extend
follow quarter also expect softer contract book
result us lower contract book estim billion
billion said expect contract book back-half make-up
shortfal first-half expect revenu affect well result
due delay go-liv lower first-half contract book given
typic take quarter convert contract book revenu lower
revenu estim billion billion revis revenu
estim toward lower-end manag guidanc rang
billion recal nearli midpoint revenu guidanc come
backlog contract revenu
long-term think could actual benefit
pandem believ pandem could increas demand healtheint
cern popul health manag platform view pandem
like enhanc valu popul health health system particularli
identifi patient popul vulner elderli
one chronic diseas addit result
may inclin make strateg acquisit particularli given significantli
discount valuat due pullback market could present upsid
manag long-term inorgan growth target well lead
believ pullback present attract opportun construct
trade adj ep estim believ share
under-valued current level given long-term growth margin profil
manag laid invest commun meet manag long-term
revenu growth target expect adj oper margin expans
bp per year impli adj oper incom growth low-doubl digit
along share repurchas reinforc view consist low- mid-teen adj
ep growth achiev believ adj ep growth low- mid-teen
rang warrant price-to-earn multipl rang histor
trade forward adj ep exclud recent downturn
thomson eikon cowen compani
lower revenu estim billion billion
billion billion respect also lower adj ep
estim respect said
maintain price target base revis dcf analysi impli
share trade adj ep estim
amount million expect per share data
cowen compani
model assumptionstermin growth tax depreci chang work pv npv free npv futur excess valu total number valu per year end decemb cowen
amount million expect per share data
compani report cowen compani
support total gross gross margin client oper oper oper incom interest incom pre-tax pre-tax incom tax incom min minor interest- net inc cont op ex-opt net incom acquisition-rel stock option expens net net incom stock option non-recurring gain net fd wtd averag ep cont op ex-opt chang incom cont cont op ex-opt option year decemb cowen
amount million expect per share data
compani report cowen compani
gross gross margin client oper oper oper incom incom pre-tax pre-tax incom tax incom min minor interest- net inc cont op ex-opt net incom acquisition-rel stock option non-recurring gain incom tax effect pre-tax net fd wtd averag ep cont op ex-opt chang incom cont cont op ex-opt cowen
amount million
compani report cowen compani
q/q q/q q/q q/q q/q q/q q/q cost total gross total gross y/i basi cowen
amount million
compani report cowen compani
asset short-term account prepaid expens current pp right-of-us assets- softwar develop cost goodwil intang long-term total current liabil account current portion long-term defer accru payrol tax accru current long-term defer incom defer minor interest- stockhold equiti common addit paid-in retain less share accumul comprehens total stockhold total liabil stockhold short-term liquid ratio current sale purchas acct ratio inventori structur long-term solvenc ratio total debt total ratio return averag total asset averag stockhold equiti cowen
amount million
compani report cowen compani
income/ loss flow oper activ depreci share base compens charg reorg busi charges- sale invest defer incom chang oper asset liabil account prepaid expens account accru incom defer current asset net cash oper acquisit properti acquisit capit softwar develop issuanc common stock- purchas treasuri dividend common proceeds/ repay debt net increase/ decreas cash equival begin cash equival end cowen summari oper capit owner financ non-recur year end decemb cowen
amount million
compani report cowen compani
flow oper activ net adjust reconcil net incom depreci share base compens provis defer incom invest gains- chang oper asset liabil net acquisit account prepaid expens account accru incom defer current asset net cash provid oper flow invest activ purchas captial purchas acquist busi net net increase/ decreas short-term capit softwar develop net cash use invest flow financ activ proce issuanc long-term repay revolv credit long-term excess tax benefit share base purchas treasuri proce exercis conting consider payment acquisit dividend paids- net cash provid financ eign currenc translat net increas decreas equival begin equival end year end decemb cowen
use five-year discount cash flow analysi primari valuat method
deriv price target gener assum discount rate may appli
appropri adjust depend compani and/or industri specif factor also
assum termin growth rate depend long-term view specif
sub-industri coverag note discount rate assumpt could view
conserv rel actual weight averag cost capit view
assumpt reason long run lower discount rate assumpt
increas termin growth rate assumpt would lead higher estim valu
per share secondari measur look forward price-to-earnings multipl ev/sal ratio
impli dcf analysi compar histor averag
potenti risk associ hcit space signific amount
spend hcit driven govern relat program high-tech act
slowdown cut program could neg impact spend hcit
constrain hospit budget could potenti lead decreas hcit-rel
invest custom loss result facil consolid inpati
outpati market could creat challeng number vendor greater price
competit hcit industri current focu meaning use incent
could delay purchas decis non-ehr relat solut servic
manag expect well set strong reason guidanc
often exceed howev low expect margin expans could provid upsid
long-term top-lin growth could expect due slower adopt
popul health cloud-bas servic slower transit saa base model
rate new client win could slower expect result book
